Literature DB >> 212975

Effect of ribavirin on viral hepatitis in laboratory animals.

R W Sidwell, J H Huffman, N Campbell, L B Allen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 212975      PMCID： PMC7168005          DOI： 10.1111/j.1749-6632.1977.tb21956.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  17 in total

1.  ANTIVIRAL COMPOUNDS. IX. STEROID DERIVATIVES.

Authors:  G CAVALLINI; E MASSARANI; D NARDI
Journal:  J Med Chem       Date:  1964-09       Impact factor: 7.446

2.  Protection against liver injury due to murine hepatitis virus.

Authors:  J D JUDAH; G BJOTVEDT; T VAINIO
Journal:  Nature       Date:  1960-08-06       Impact factor: 49.962

3.  Propagation of equine abortion virus in Syrian hamsters.

Authors:  E R DOLL; J T BRYANS; W H MCCOLLUM; E W CROWE
Journal:  Cornell Vet       Date:  1956-01

4.  Studies on hepatitis in hamsters infected with equine abortion virus. I. Sequential development of inclusions and the growth cycle.

Authors:  C C RANDALL; E C BRACKEN
Journal:  Am J Pathol       Date:  1957 Jul-Aug       Impact factor: 4.307

5.  Antiviral agents. II. Substituted morpholinium quaternary salts.

Authors:  E L Anderson; J E Casey; E E Force; E M Jensen; R S Matz; D E Rivard
Journal:  J Med Chem       Date:  1966-03       Impact factor: 7.446

6.  In vivo and in vitro inhibition of hepatitis viruses by streptothricin.

Authors:  R L Stone; D C DeLong; R N Hull; I S Johnson
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

7.  The relationship between the metabolism of ribavirin and its proposed mechanism of action.

Authors:  J P Miller; L J Kigwana; D G Streeter; R K Robins; L N Simon; J Roboz
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

8.  [Action of 1-beta-D-ribofuranosyl, 1,2,4-triazol-3-carboxamide on the treatment of acute viral hepatitis].

Authors:  C B Zuñiga; C de Almeida; A C Iervolino; I de O Castro; P A Galvão
Journal:  AMB Rev Assoc Med Bras       Date:  1974-11

9.  Glutamic-oxaloacetic transaminase activity of serum in mice with viral hepatitis.

Authors:  C FRIEND; F WROBLEWSKI; J S LA DUE
Journal:  J Exp Med       Date:  1955-12-01       Impact factor: 14.307

10.  Viral hepatitis associated with transplantable mouse leukemia. I. Acute hepatic manifestations following treatment with urethane or methylformamide.

Authors:  H BRAUNSTEINER; C FRIEND
Journal:  J Exp Med       Date:  1954-12-01       Impact factor: 14.307
View more
  6 in total

1.  Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A).

Authors:  R W Sidwell; J H Huffman; E W Call; R P Warren; L A Radov; R J Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

2.  In vitro and in vivo Phlebovirus inhibition by ribavirin.

Authors:  R W Sidwell; J H Huffman; B B Barnett; D Y Pifat
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

3.  Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators.

Authors:  Rahul Shubhra Mandal; Atri Ta; Ritam Sinha; Nagaraja Theeya; Anirban Ghosh; Mohsina Tasneem; Anirban Bhunia; Hemanta Koley; Santasabuj Das
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

Review 4.  Development of antiviral therapy for severe acute respiratory syndrome.

Authors:  Jindrich Cinatl; Martin Michaelis; Gerold Hoever; Wolfgang Preiser; Hans Wilhelm Doerr
Journal:  Antiviral Res       Date:  2005-04-26       Impact factor: 5.970

5.  Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity.

Authors:  Gary A Levy; Gord Adamson; M James Phillips; Louise A Scrocchi; Laisum Fung; Pieter Biessels; Nancy F Ng; Anand Ghanekar; Andrea Rowe; Max Xuezhong Ma; Adam Levy; Cheryl Koscik; William He; Reginald Gorczynski; Steve Brookes; Caroline Woods; Ian D McGilvray; David Bell
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

Review 6.  [Severe acute respiratory syndrome: update].

Authors:  P Bossi; A Guihot; S Ansart; F Bricaire
Journal:  Rev Med Interne       Date:  2003-10       Impact factor: 0.728
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.